drugset / Trial / NCT00004806
Phase I Study of Liposome-Mediated Gene Transfer in Patients With Cystic Fibrosis
Phase 1
Completed
9 enrolled
University of Alabama at Birmingham
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · collab
Treatment
Summary
OBJECTIVES: Evaluate the efficacy and safety of lipid-mediated transfer of the cystic fibrosis transmembrane conductance regulator gene to nasal epithelium in patients with cystic fibrosis.
Timeline
- Start
- 1995-06
- Primary completion
- 2002-11
- Completion
- 2002-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cystic fibrosis transmembrane conductance regulator | Other / unclassified | — | Intranasal |